Article

Clinical Trial: Long-term Cardiovascular Risk in Cured Cushing's Patients

This trial aims to determine if patients who have had Cushing's syndrome in the past maintain characteristics that are different than patients who have never been diagnosed with the disease.

Long-term Cardiovascular Risk in Cured Cushing's Patients

Study Type: Observational

Age/Gender Requirements: 35-55 years (female)

Sponsor: Massachusetts General Hospital

Purpose: To determine if patients “who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.”

Click here to access this third-party resource.

Related Videos
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Optimizing Diabetes Therapies with New Classifications
© 2024 MJH Life Sciences

All rights reserved.